UK Dermatology Market Analysis Sample Report

UK Dermatology
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the UK Dermatology Market
and a forecast for its development in the medium and long term. It provides
a comprehensive overview of the market value, dynamics, segmentation,
characteristics, main players, trends and insights, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the UK Dermatology Market, and offers
unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Major Dermatology Disease
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Conclusion

4 A Sample Report on UK Dermatology Market Analysis I Confidential
Table of Contents
1 UK Dermatology Market Overview..……………….….……………………………………………….....…............................................06
1.1 Introduction
1.2 Prevalence of Dental Problems in Britishers
1.3 Market size and forecast
1.4 Dermatologists in Market
2. Market Growth Drivers and Restraints ……………………….……..…………..…………………....…..............................................11
2.1 Market Growth Drivers
2.1.1 Increasing Awareness
2.1.2 Social Media Influence
2.1.3 Increasing Skin Diseases
2.2 Market Restraints
2.2.1 Scarce Workforce
2.2.2 Social Anxiety hindering visits
2.2.3 High Treatment Cost
3. Major Dermatology Diseases…………………………….……………………….……………..……………………………….......……..17
3.1 Eczema
3.2 Psoriasis
3.3 Melenoma

Table of Contents (continued)
4. UK Dermatology Analysis: Market Segmentation……….….……..………………………………..………………..…..…..…...........19
4.1 UK Dermatology Market Segmentation: By Product Group
5. Dermatology Services Major Market Share……...…..………………..………….……………………………………...........…...…….24
5.1 Dermatology Services Market Share: By Revenue
6. Competitive Landscape………………………………………………………………………………………..…….………..………….…..26
6.1 Major Players
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….……………….....…...……….28
7.1 Pfizer
7.2 Takeda
7.3 Arcrutis
7.4 Verrica
7.5 Soligenix
8. Healthcare Policies and Regulatory Landscape………………………………….……………………………………….………...…...34
8.1 Policy Changes and Reimbursement Scenario
9. Future Development Growth………………………………………………………..………………………………………………….…....36
9.1 Future Opportunities
10. Conclusion……………………..……………………………………………………………………………….………….…...…................38
10.1 Conclusion

UK Dermatology Market Analysis
1. Overview

1.1 Introduction
▪ Dermatology includes segments like medical dermatology, dermatopathology, pediatric dermatology, cosmetic dermatology,
and others
▪ Skin ailments like Acne, rosacea and eczema are the most common reasons for patients to visit dermatologists
▪ Owing to the weather conditions in UK, a major chunk of population suffers skin diseases making it a desirable market for
pharma companies

▪ 60% of Britishers have or had some type of skin disease
at some point in their lifetime
▪ XX% of British children have eczema
▪ XX% Britishers have skin problems or scars which affects
their confidence levels
Key Analysis
Skin Problems in Britishers
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
xx
60%
1.2 Prevalence of Skin Problems in Britishers

▪ The UK dermatology market is expected to grow from
$XX Mn in 2022 to $XX Mn in 2030 with a CAGR of 8.8%
for the forecasted year 2022-2030.
▪ OTC drugs hold a major chunk of the dermatology market
Key Analysis
1.3 Market Size & Forecast

Number of Dermatologist in UK (in ’00)
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
XX
10
▪ In June 2022, there were only xxx number of dermatology
consultants, paired with xxx specialty dermatologists in
the UK
▪ While the number of dermatologists increases, the
number of patients is increasing at a faster pace
Key Analysis
1.4 Dermatologists in UK Market

2. Growth Drivers & Restraints

UK Dermatology: Market Drivers & Restraints
Social Media
Influence
Increasing
Awareness
Increasing Skin
Diseases
Scarce
Workforce
Restraints
High Treatment
Cost
Social Anxiety
hindering visits
Drivers

2.1 Market growth drivers (continued)
2.1.1 Increasing Awareness
▪ Still, people of lower socio-economic background does not have sufficient information regarding the adverse
impact of sun exposure
▪ With the increasing level of literacy and awareness by pharma and MNC advertisements, People are aware of
when a disease needs due attention and treatment

Market growth drivers (continued)
2.1.2 Social Media Influence
▪ Increased accessibility to desirable looks via cosmetic surgery and treatments, dermatology market is thriving
▪ With increasing social media and vloggers, people are more and more active on social media. The UK has almost
~100,000 social media influencers who need to maintain a decent look

Market growth drivers (continued)
2.1.3 Increasing Skin Diseases
▪ ~140,000 Britishers suffers form psoriasis and such rising incidence had made Britishers vigilant
▪ Every year, at least 100,000 skin cancer cases are reported. Melanoma is the most common skin cancer, which
has increased by 32% in the past decade

2.2 Market Restraints
2.2.3 Social Anxiety Hindering Visits
▪ Social Anxiety with the idea of being
surrounded by people and being
watched restricts patients to visit the
doctors
▪ With the visuals of the disease
being more disturbing, patients are
often at risk to depression, which
hinders the pace of treatment
▪ 1 in every 10 people in UK have
some kind of social anxiety disorder
2.2.2 High Treatment Cost
2.2.1 Scarce Workforce
▪ UK trains only half of the doctors
that it needs and still is decreasing
seats in the universities
▪ It relies heavily on Africa and South-
East Asia

3. Major Dermatology Diseases

3. Major Dermatology Diseases
3.2 Psoriasis
▪ Psoriasis is a skin condition that
causes flaky patches of skin with
sore or itchy patches
▪ 2 in every 100 of people in UK has
psoriasis
▪ Severity of the diseases varies from
person to person
3.1 Dermatitis/ Eczema
▪ Eczema is a non-contagious
inflammatory dry skin condition
which can happen to people of any
age
▪ 1 in every 5 children and 1 in every
10 adults in UK has Atopic Eczema,
the most common form
▪ UK being a cold weathered country
is prone to Eczema
3.3 Melanoma
▪ Melanoma is caused by abnormally
developed skin cells
▪ Melanin- that gives color to the skin
and turns the skin cancerous
▪ It is the most serious type of skin
cancer
▪ Every year ~16,000 new cases of
Melanoma occur in UK

4. Market Segmentation

UK Dermatology Market Segmentation
UK Dermatology Market Segmentation
By Type
By Route Of
Administration

Snapshot Of UK Dermatology Market Analysis Segmentation
By Route Of Administration
By Type
▪ Prescription-
based drugs
▪ Over-the-counter
drugs
▪ Topical
administration
▪ Oral
administration
▪ Parenteral
administration

Prescription-based drugs Over-the-counter drugs
▪ OTC drugs are being sold in the majority out of which pain
relief medicines are being sold the most.
▪ In 2022 alone, painkillers worth ₤ xx Mn have been sold
followed by vitamins and nutraceuticals
4.1 Market Segmentation: By Type
UK Dermatology Market Share by Type (2021) Key Insights

4.2 Market Segmentation: By Route Of Administration
UK Dermatology Market Share: By Route Of Administration
(2022)
Topical administration Oral administration Parenteral administration
Key Insights

5. Major Product Market Share

5.1 UK Dermatology Market Share
Brands in UK Dermatology Market
Dermatology Services Major Market Share: By Revenue
Brand 1 Brand 2 Brand 3 Brand 4 Brand 5

6. Competitive Landscape

6.1 Competitive Landscape: Key Players Revenue (Current and Forecasted)
Major Market Revenue of UK Dermatology Companies ($Bn)
2022 Key Insights
Pfizer $xx
Takeda $xx
Arcutis $xx
Verrica $xx
Soligenix $xx

7. Key Company Profiles

7.3 Pfizer Inc. UK
▪ Pfizer is an American Multi-national pharmaceutical company
dealing with various drugs and vaccines with breakthrough
products
Year of Establishment: 1848
Headquarters: New York, USA
Website:https://www.pfizer.com/sites/default/fil
es/investors/financial_reports/annual_reports/2
021/
Revenue (US): $81,288 Mn
Company Name: Pfizer UK
Company at a Glance
Company Overview

7.1 Takeda Pharmaceuticals
▪ A international pharmaceutical firm with some American and
British roots, The Takeda Pharmaceutical Company Limited is
based in Japan
Headquarter: Tokyo, Japan
Website: https://www.takeda.com/en-gb/
Revenue (US): $ 27.4 Bn
Company Name: Takeda Pharmaceuticals
Company at a Glance
Company Overview

7.5 Arcutis Biotherapeutics
▪ Arcutis has an extensive medical dermatology development
expertise and it works to fulfill the unmet needs through
meaningful innovation
Headquarters: California, US
Website: https://www.arcutis.com/
Revenue (US): $ 25 Mn
Company Name: Arcutis Biotherapeutics
Company at a Glance
Company Overview

7.2 Verrica Pharmaceuticals
▪ Verrica Pharmaceuticals is a dermatology specific
pharmaceutical company developing medications for skin
disease
Headquarters: Pennsylvania, US
Website: https://verrica.com/
Revenue (US): $12 Mn
Company Name: Verrica Pharmaceuticals
Company at a Glance
Company Overview

7.4 Soligenix
▪ Soligenix is a company who develops and capitalizes products
on rare diseases, where is a medical unmet need
Headquarters: New Jersey, US
Website: https://www.soligenix.com/
Revenue (US): $xx Mn
Company Name: Soligenix
Company at a Glance
Company Overview

8. Healthcare Policy and Regulatory Landscape

8.1 Policy and reimbursement scenario
▪ UK has 2 public health insurance schemes
▪ National Health Services NHS)
▪ Medicaid
▪ Almost ~xx% of the population already has private or voluntary health insurance
▪ While, UK’s population does not pay for consultations charges, there is a copayment structure for drugs and the drugs eligible
for reimbursement are known to the insurers

9. Factors Driving Future Growth

9.1 Future Opportunities
.
In order to live up to the
standard of the social media
lives……..
Technological advances in
skin treatments like………..
The rising preference for
Skin diseases is going
to…….

10. Conclusion

10.1 Conclusion
1
2
3
5
4
Increasing Skin Diseases Insurance Scenario
With 2 categories of insurance,
dermatology is an exception to......
Preference for flawless skin
Social media is increasing the
global business of …….
Stigma
Increasing support……
OTC Drugs availability
Prices of treatment for all the patients
including……
Due to increasing munching
habits in younger
population……

▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
Research Methodology

Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Analysis Methodology

Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
Data Triangulation & Data Validation

Study provides an in-depth analysis of the Global Patient Support Program market with current trends and future estimations to
elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Key Benefits for Stakeholders From This Report

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

UK Dermatology Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to UK Dermatology Market Analysis Sample Report

Similar to UK Dermatology Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

UK Dermatology Market Analysis Sample Report